| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Aptevo Therapeutics Inc.
13G
APVO · 03835L702
|
12.2% |
6/22/2026
Event 5/25/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.